Recent Posts
- AIM ImmunoTech Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
- AIM ImmunoTech Announces Election of Three Incumbent Board Members at Annual Meeting
- AIM ImmunoTech Reminds Shareholders to Vote “FOR” All Four Incumbent Board Members on the WHITE Universal Proxy Card
- AIM ImmunoTech Urges Shareholders to Vote on the WHITE Universal Proxy Card “FOR” All Four Incumbent Board Members
- AIM ImmunoTech Expands Patent Portfolio with New Netherlands Composition and Methods Patent Covering Ampligen for Use in the Post-COVID Condition of Fatigue
Recent Comments
No comments to show.